Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
Esteban Cruz, Veysel KayserSchool of Pharmacy, The University of Sydney, Sydney, NSW, AustraliaAbstract: Monoclonal antibodies (mAbs) have become a cornerstone in the therapeutic guidelines of a wide range of solid tumors. The targeted nature of these biotherapeutics has improved treatment outcomes...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-05-01
|
| Series: | Biologics : Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/monoclonal-antibody-therapy-of-solid-tumors-clinical-limitations-and-n-peer-reviewed-article-BTT |